Sponsor

Enanta Pharmaceuticals Inc.

United States 4 Kingsbury Avenue, 02472-5789, United States

About the sponsor

Clinical research activity is centered on RSV in non-hospitalized adults, with attention to acute infection and the risk of complications in higher-risk populations.

Acute respiratory infection
Complication risk in adults
Outpatient viral illness

The sponsor’s current research focus is directed toward clinical outcomes linked to symptom progression during respiratory syncytial virus infection.

About Specializations

Enanta Pharmaceuticals Inc. runs clinical trials in conditions such as Respiratory syncytial virus infection, among others.

Respiratory syncytial virus infection

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Respiratory syncytial virus infection

Not recruiting

Investigational

Study on the Effectiveness and Safety of EDP-938 for Adults with High-Risk Respiratory Syncytial Virus (RSV) Infection

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Zelicapavir
Sponsor:Enanta Pharmaceuticals Inc.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →